Država: Malta
Jezik: engleski
Izvor: Medicines Authority
FINASTERIDE
Cipla (EU) Limited Hillbrow House, Hillbrow Road, Esher, Surrey, KT10 9NW, United Kingdom
G04CB01
FINASTERIDE 5 mg
FILM-COATED TABLET
FINASTERIDE 5 mg
POM
UROLOGICALS
Withdrawn
2015-01-27
PACKAGE LEAFLET: INFORMATION FOR THE USER FINASTERIDE 5MG FILM-COATED TABLETS (FINASTERIDE) This medicine is for use in men only READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed to you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Finasteride is and what it is used for 2. What you need to know before you take finasteride 3. How to take Finasteride 4. Possible side effects 5. How to store Finasteride 6. Contents of the pack and other information 1. WHAT FINASTERIDE IS AND WHAT IT IS USED FOR The name of your medicine is Finasteride 5 mg Film-coated Tablets. Finasteride tablets are film- coated tablets and contain the active ingredient finasteride. This belongs to a group of medicines called ‘testosterone-5-alpha reductase inhibitors’. Finasteride shrinks the prostate gland in adult men when it is swollen. The prostate gland is found underneath the bladder (but only in men). It produces the fluid found in semen. A swollen prostate gland can lead to a condition called ‘benign prostatic hyperplasia’ or BPH. WHAT IS BPH? If you have BPH it means that your prostate gland is swollen. It can press on the tube that urine passes through, on its way out of your body. This can lead to problems such as: • feeling like you need to pass urine more often, especially at night • feeling that you must pass urine right away • finding it difficult to start passing urine • when you pass urine the flow of urine is weak • when you pass urine the flow stops and starts • feeling that you cannot empty your bladder completely In some men, BPH can lead to mo Pročitajte cijeli dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Finasteride 5 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of finasteride Excipients include lactose monohydrate (see section _4.3_ ). For a full list of excipients, see section _6.1_ . 3 PHARMACEUTICAL FORM Film-coated tablet Finasteride tablets are light blue, circular, biconvex, film coated tablets, debossed with FIN on one side and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Finasteride is indicated for the treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to: − cause regression of the enlarged prostate, improve urinary flow and improve the symptoms associated with BPH − reduce the incidence of acute urinary retention and the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended adult dose is one 5 mg tablet daily, with or without food. 'Finasteride' can be administered alone or in combination with the alpha-blocker doxazosin (see section 5.1). Although early improvement in symptoms may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. Thereafter, treatment should be continued long term. Page 1 of 10 No dosage adjustment is required in the elderly or in patients with varying degrees of renal insufficiency (creatinine clearances as low as 9 ml/min). There are no data available in patients with hepatic insufficiency. 'Finasteride' is contra-indicated in children. 4.3 CONTRAINDICATIONS Finasteride is not indicated for use in women or children. Finasteride is contraindicated in the following: • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Pregnancy - Use in women when they are or may potentially be pregnant. (see section 4.6 Pregnancy and lactation, Exposure to finasteride - risk to male fetus). 4.4 SPEC Pročitajte cijeli dokument